A few days ago @paulf submitted an informative post which proposed that Caris James may not be a person but rather shorthand for the CARribbean ISland of Little St. JAMES - Epstein's place. A lot of good digging was manifested with this post but it was eventually flaired as Debunked based on the evidence.

https://voat.co/v/pizzagate/comments/3056745

Now, I will try another stab at the mystery, but I am not the first mentioning this theory. It has been discussed piecemeal in the past on Steemit, Redditt, Twitter, and elsewhere.

Enter Caris Life Sciences, Inc. (CLS)

Founded in 1987, based in Irving, TX, with additional offices in Phoenix, AZ, and Basel, Switzerland. Serving customers through distributors in the U.S., Europe, Australia, and internationally.

CLS operates as a bioscience company, engaging in the developments and commercialization of anatomic pathology, drug development and delivery, molecular profiling, and blood based diagnostic technologies in the fields of oncology, dermatopathology, hematopathology, gastrointestinal pathology, and urologic pathology.

It also offers advanced molecular analyses of patient samples through prognostic testing services and genomic, ADAPT Biotargeting System, Caris Molecular Intelligence, transcriptomic, and proteomic profiling. Do I understand all of this? No.

Dr. David D. Halbert, age 62, is the Chairman and CEO.

This company is HUGE.

http://20www.bloomberg.com/research/stocks/private/snapshot.aspundefined

https://www.carislifesciences.com/about/

About David Halbert - He graduated from Abilene Christian University in 1978 with a BS in business administration. Prior to founding CLS, he founded AdvancePCS, a leading pharmacy benefits management company, where he served as Chairman and CEO until it was sold to CareMark in 2004 for $7.5 billion. Under Halbert, the small, privately-owned AdvancePCS, grew into a publicly traded Fortune 250 corporation with over $15 billion in annual revenue. When AdvancePCS was sold, it returned 31 times its initial IPO value, 150 times the venture capital investment, and 227 times the original investor's money.

Thereafter, Halbert formed Caris Capital in 2005 and has sold over $1.2 billion in assets. He also acquired Pathology Partners, Inc., in 2005, based in Irving, TX, which was later renamed Caris Diagnostics. He served as Chairman of the Nutrition and Scientific Advisory Boards of Herbalife International of America, Inc., and as Independent Director of Herbalife Ltd. from March 2006 to May 2007. In 2008, he acquired Molecular Profiling Institute (MPI), a molecular life sciences company. In 2011, Caris Diagnostics was sold to Miraca Life Sciences for $725 million.

CLS explains itself as being exclusively focused on fulfilling the promise of personalized medicine, and by using sophisticated disease profiling technologies along with advanced bioinformatics capabilities, they are pioneering a new era in precision medicine.

https://www.carislifesciences.com/about/

http://20www.bloomberg.com/research/stocks/private/person.aspundefined

Halbert and his family also solely support the Caris Foundation, a non-profit, private foundation established in 2002, that aids impoverished people by implementing solutions that are culturally relevant and sustainable across Africa and Haiti. The foundation primarily operates in Kenya and Haiti and employs more than 167 people. It also funds relief efforts in Haiti, Guatemala, Peru, Kenya, Indonesia, the Philippines, and China, with a focus on preventing and treating pediatric HIV and other life-threatening diseases.

http://www.carisfoundation.org/welcome#about

https://www.acu.edu/via/kathy-and-david-halbert.html

On December 5, 2017, the United States Agency for International Development (USAID) announced their selection of Caris Foundation International to lead a consortium of partners to bolster Haiti's health system and expand essential healthcare for up to 4.2 million people - spending $98.5 million over 4 years.

http://www.carisfoundation.org/news/2017/12/8/new-us-governmentcaris-foundation-cooperative-agreement

How did Dr. David Halbert, with only a bachelor's degree in business administration from Abilene Christian University, become so successful and wealthy? According to Forbes, Abilene U. ranks #463 in Top Colleges, #305 in Private Colleges, and #95 in the South. I found no evidence whatsoever that he continued his education beyond an undergraduate level, earning the title of "Doctor."

David D. Halbert's grandfather had become rich on Texas oil, and his father was a prominent Abilene physician who led the building of one of the city's hospitals. After completing his degree in business administration, he began working in the oil and gas industry, as did his younger brother, Jon. In the mid-1980's, both David and Jon took an interest in the rising trend of home healthcare and began looking for investors to start a mail order pharmacy, whcih they called Advance Paradigm and later became AdvancePCS. One of the original investors in Advance Paradigm was George W. Biush. Halbert's career took off.

In 2001, then President George W. Bush came under fire for his business connections with Halbert in the mid-1990's. Halbert and his family had contributed funds to several of Bush's campaigns. Bush had sold off his stocks in Halbert's Advance Paradigm in 1998 to avoid a conflict of interest. The two had remained friends, however, and Bush approached Halbert in 2001 to help write a controversial proposal to offer drug discount cards to seniors. Many felt the move was inappropriate because AdvancePCS stood to benefit from the program if Medicare endorsed the company to issue the cards. The Medicare Prescription Drug Discount Card Program was enacted into law on December 8, 2003.

https://www.forbes.com/colleges/abilene-christian-university/

https://www.referenceforbusiness.com/biography/F-L/Halbert-David-D-1956.html

Caris Life Sciences and all of its many subsidiaries is about precision medicine, and precision medicine flunks the test of clinical utility. There have been great achievements in identifying and characterizing the genetic underpinnings for many diseases. which has resulted in a much deeper understanding of many diseases. In the broader sense, however, the application of genetic information has not yet been shown to be helpful, despite all the hype suggesting otherwise.

Now, a new study gives strong evidence that broad scale general use of genetic information will have very little value in guiding health decisions and even has the potential to cause far more harm than good. In particular, the study shows that "incidental" findings from genetic screening strategies have a very long way to go before living up to the hype of precision medicine advocates. The ethical implications are huge. The study "provided de facto evidence of a high false-positive rate for variant interpretation."

http://www.cardiobrief.org/2016/01/05/jama-study-precision-medicine-flunks-test-gets-left-back-in-second-grade/

In August of 2016, Caris Life Sciences announced that it had surpassed 100,000 clinical trials with its tumor profiling offering. And the money never stops. In October 2018, CLS announced that it had raised $150 million in growth capital in the form of secured debt and convertible notes from TPG Sixth Street Partners (TSSP), the global credit investment platform with $25 billion in assets under management. Caris will use the proceeds (in part) to continue development of "Next Generation Profiling."

https://www.carislifesciences.com/news/caris-life-sciences-raises-150-million-growth-capital-tpg-sixth-street-partners/

This is just one more deep, deep rabbit hole with so many companies, corporations, and people involved. It's very difficult to determine how many companies are affiliated with, managed by, or owned by David D. Halbert. I believe it is fair to say that very little, if anything, of what Halbert does is for the goodness of mankind.

So, is #carisjames in any way connected to Caris Life Sciences? Is Caris Life Sciences connected in any way to #carisjames? I believe it's fair to say that we still don't know.